Title : Preclinical discovery and development of abemaciclib used to treat breast cancer.

Pub. Date : 2021 May

PMID : 33280445






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 One such inhibitor, abemaciclib, a reversible ATP-competitive CDK4/6 inhibitor developed by Eli Lilly and Company, was approved by the FDA for ER-positive, HER2-negative metastatic breast cancer. abemaciclib epiregulin Homo sapiens